Literature DB >> 478563

Biological properties of human melanoma cells in culture.

A A Creasey, H S Smith, A J Hackett, K Fukuyama, W L Epstein, S H Madin.   

Abstract

Three human melanoma cell lines derived from one primary and two metastatic tumors from three different patients were characterized for growth properties usually associated with malignant transformation; these include cell morphology, growth rate, saturation density, growth in semisolid media, colony-forming ability on contact-inhibited monolayers of normal fibroblasts and epithelial cells, and tumorigenicity in immunosuppressed mice. Variations in expression of aberrant properties were evident among the lines. One of the metastatic lines satisfied all the parameters of malignancy tested and the other showed a number of these properties, whereas the primary essentially fulfilled only one. These results suggest that cultured melanoma cells reflect the clinical variability often observed among melanoma patients and that metastatic melanoma seems to display a higher degree of malignant transformation than the primary.

Entities:  

Mesh:

Year:  1979        PMID: 478563     DOI: 10.1007/bf02616140

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  24 in total

1.  Organ specificity of blood-borne tumour metastasis determined by cell adhesion?

Authors:  G L Nicolson; J L Winkelhake
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

2.  Common and individually specific chromosomal characteristics of cultured human melanoma.

Authors:  P B McCulloch; P B Dent; P R Hayes; S K Liao
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

3.  Heterotransplantation model of human malignant melanoma.

Authors:  B Mukherji; A Flowers; L Nathanson; D A Clark
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

4.  Stable chromosome changes in human malignant melanoma.

Authors:  T R Chen; M W Shaw
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

5.  Suspension culture of a pigment-producing cell line derived from a human malignant melanoma.

Authors:  H F Oettgen; T Aoki; L J Old; E A Boyse; E de Harven; G M Mills
Journal:  J Natl Cancer Inst       Date:  1968-10       Impact factor: 13.506

6.  Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells.

Authors:  B C Giovanella; S O Yim; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

7.  Separation of murine cellular and murine leukaemia virus DNA polymerases.

Authors:  J Ross; E M Scolnick; G J Todaro; S A Aaronson
Journal:  Nat New Biol       Date:  1971-06-09

8.  In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue.

Authors:  H S Smith
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

9.  Establishment of a cell line (SH-4) from pleural effusion of a patient with melanoma.

Authors:  G Seman; S J Hunter; J M Lukeman; L Dmochowski
Journal:  In Vitro       Date:  1975 Jul-Aug

10.  The biology of human cells in tissue culture. I. Characterization of cells derived from osteogenic sarcomas.

Authors:  H S Smith; R B Owens; A J Hiller; W A Nelson-Rees; J O Johnston
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

View more
  17 in total

1.  SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation.

Authors:  Melissa J Wilking; Chandra Singh; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  Arch Biochem Biophys       Date:  2014-04-18       Impact factor: 4.013

2.  Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.

Authors:  C W Czarniecki; C W Fennie; D B Powers; D A Estell
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

3.  Biological and biochemical properties of a human uveal melanocyte-derived cell line.

Authors:  F L Meyskens; E B Berglund; D F Saxe; B B Fuller; L Z Pacelli; J D Hall; C G Ray
Journal:  In Vitro       Date:  1980-09

4.  Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.

Authors:  N Kamatani; W A Nelson-Rees; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme.

Authors:  Yukihito Kabuyama; Elizabeth S Litman; Paul D Templeton; Sandra I Metzner; Eric S Witze; Gretchen M Argast; Stephen J Langer; Kirsi Polvinen; Yiqun Shellman; Daniel Chan; John B Shabb; James E Fitzpatrick; Katheryn A Resing; Marcelo C Sousa; Natalie G Ahn
Journal:  Mol Cell Proteomics       Date:  2009-07-20       Impact factor: 5.911

6.  Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.

Authors:  Jinming Yang; Snjezana Zaja-Milatovic; Yee-Mon Thu; Francis Lee; Richard Smykla; Ann Richmond
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

7.  CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.

Authors:  Yukiko Ueda; Yingjun Su; Ann Richmond
Journal:  Melanoma Res       Date:  2007-04       Impact factor: 3.599

8.  Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon.

Authors:  A A Creasey; J C Bartholomew; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  An Endogenous Electron Spin Resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application.

Authors:  Eleonora Cesareo; Liudmila Korkina; Gerardino D'Errico; Giuseppe Vitiello; Maria Simona Aguzzi; Francesca Passarelli; Jens Z Pedersen; Antonio Facchiano
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin.

Authors:  A Richmond; E Balentien; H G Thomas; G Flaggs; D E Barton; J Spiess; R Bordoni; U Francke; R Derynck
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.